met-4
Showing 1 - 2 of 2
Advanced Head and Neck Squamous Cell Carcinoma Trial (Pembrolizumab, MET-4, Placebo)
Not yet recruiting
- Advanced Head and Neck Squamous Cell Carcinoma
- Pembrolizumab
- +2 more
- (no location specified)
Feb 22, 2023
Head and Neck Squamous Cell Carcinoma Trial in Toronto (MET-4)
Active, not recruiting
- Head and Neck Squamous Cell Carcinoma
- MET-4
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Jan 8, 2023